The heterogeneity of PLK2 and TAp73 expression in HCOS, which is related to the maldifferentiation of osteoblastic osteosarcoma and chondroblastic osteosarcoma, affects patient prognosis. Here, PLK2 is linked to osteoblastic osteosarcoma.